In his complaint, Michael Wade Nance said his veins were so severely compromised that they were likely to blow and cause him ...

This episode, titled Optimizing Subcutaneous Therapies in NSCLC: Practical Integration, Patient Selection, and Workflow ...

Forlong Biotechnology, a clinical-stage biotech company focusing on developing transformative cytokine therapies for patients with severe unmet needs, today announced that preclinical data from its IL ...

T cells are supposed to be relentless. These white blood cells patrol the body, identify threats, and destroy them.

True IgE-mediated local anesthetic hypersensitivity is <1% of reported reactions, so risk reduction should prioritize preservative-free amide selection, minimal effective dosing, and strict avoidance ...

Injections of botulinum toxin, commonly known as Botox, could be an effective and well-tolerated option for treating debilitating complications caused by reduced blood flow to the fingers, such as ...

Pharmacosmos initiates phase III clinical trial of trilaciclib in limited-stage small cell lung cancer MORRISTOWN, NJ, ...

These presentations collectively demonstrate how we’re addressing the key challenges that have limited success in Alzheimer’s drug development – delivery, measurement, timing, and selectivity,” said ...

Ontario’s move to pull funding for London’s only supervised drug consumption site could worsen overdoses and health risks in a city already struggling with homelessness and addiction, health officials ...

LEO Pharma A/S, a global leader in medical dermatology, today announced it will present 17 scientific posters at the 2026 American Academy of Dermatology (AAD) Annual Meeting (March 27-31, Denver, ...

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that its Board of Directors has ...